Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M15,124Revenue (TTM) $M974Net Margin (%)-54.5Altman Z-Score7.0
Enterprise Value $M15,291EPS (TTM) $-3.3Operating Margin %-65.1Piotroski F-Score2
P/E(ttm)--Beneish M-Score-2.9Pre-tax Margin (%)-68.8Higher ROA y-yN
Price/Book7.910-y EBITDA Growth Rate %--Quick Ratio2.1Cash flow > EarningsY
Price/Sales15.35-y EBITDA Growth Rate %--Current Ratio3.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-15.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-23.6Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M163ROIC % (ttm)-21.4Gross Margin Increase y-yN

Gurus Latest Trades with BMRN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BMRNJoel Greenblatt 2016-06-30 Buy $74.61 - $93.8
($84.98)
$ 92.529%New holding3,144
BMRNJoel Greenblatt 2015-06-30 Sold Out $112.05 - $140
($123.93)
$ 92.52-25%Sold Out0
BMRNJoel Greenblatt 2015-03-31 Buy $90.28 - $129.14
($105.95)
$ 92.52-13%New holding4,195
BMRNJoel Greenblatt 2014-12-31 Sold Out $67.27 - $94.19
($83.42)
$ 92.5211%Sold Out0
BMRNJoel Greenblatt 2014-09-30 Buy $55.78 - $73
($65.82)
$ 92.5241%New holding3,885
BMRNMeridian Funds 2013-06-30 Sold Out -0.09%$54.72 - $70.3
($62.32)
$ 92.5248%Sold Out0
BMRNMeridian Funds 2013-03-31 Reduce-0.17%$49.2 - $62.39
($56.51)
$ 92.5264%Reduce -69.03%40,700
BMRNMeridian Funds 2012-12-31 Reduce-0.3%$36.78 - $50.17
($45.59)
$ 92.52103%Reduce -60.99%131,400
BMRNGeorge Soros 2012-06-30 Sold Out -0.15%$32.53 - $38.87
($36.01)
$ 92.52157%Sold Out0
BMRNGeorge Soros 2012-03-31 Add0.11%$33.68 - $38.34
($32.99)
$ 92.52180%Add 300.00%300,000
BMRNGeorge Soros 2011-12-31 Reduce-0.05%$30.07 - $35.38
($32.81)
$ 92.52182%Reduce -57.14%75,000
BMRNGeorge Soros 2011-06-30 Add0.07%$24.93 - $28.455
($26.32)
$ 92.52252%Add 862.36%191,510
BMRNMeridian Funds 2011-03-31 Reduce-0.28%$23.46 - $28.29
($25.46)
$ 92.52263%Reduce -51.54%348,800
BMRNGeorge Soros 2011-03-31 Buy 0.01%$23.46 - $28.29
($25.46)
$ 92.52263%New holding19,900
BMRNGeorge Soros 2010-09-30 Sold Out -0.02%$18.24 - $23.09
($20.93)
$ 92.52342%Sold Out0
BMRNMeridian Funds 2010-03-31 Add0.13%$18.75 - $23.81
($20.92)
$ 92.52342%Add 20.83%795,900
BMRNGeorge Soros 2010-03-31 Add$18.75 - $23.81
($20.92)
$ 92.52342%Add 35.87%30,300
BMRNGeorge Soros 2009-12-31 Buy 0.01%$15.49 - $18.98
($17.17)
$ 92.52439%New holding22,300
BMRNMeridian Funds 2009-09-30 Buy 0.53%$13.86 - $18.33
($15.84)
$ 92.52484%New holding658,700
BMRNBill Gates 2009-06-30 Sold Out -0.02%$11.92 - $15.94
($13.79)
$ 92.52571%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BMRN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


BMRN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Ajer Jeffrey RobertEVP, Chief Commercial Officer 2016-09-27Sell18,467$95.61-3.23view
BIENAIME JEAN JACQUESCEO 2016-09-16Sell137,368$95.34-2.96view
FUCHS HENRY JEVP, Chief Medical Officer 2016-08-26Sell15,000$95.06-2.67view
BIENAIME JEAN JACQUESCEO 2016-08-16Sell41,666$91.491.13view
SPIEGELMAN DANIEL KEVP, CFO 2016-08-01Sell4,000$99.33-6.86view
Davis George EricEVP, General Counsel 2016-08-01Sell2,167$100-7.48view
Mueller BrianVP, Corporate Controller 2016-08-01Sell287$100-7.48view
LAWLIS V BRYANDirector 2016-07-27Sell1,100$95.39-3.01view
LAWLIS V BRYANDirector 2016-07-22Sell6,400$95.01-2.62view
BIENAIME JEAN JACQUESCEO 2016-07-18Sell41,666$92.72-0.22view

Press Releases about BMRN :

Quarterly/Annual Reports about BMRN:

News about BMRN:

Articles On GuruFocus.com
Low Valuation Ratios Lead to Strong Portfolio Returns Sep 13 2016 
Sam Isaly Swaps 3 Health Care Stocks in Second Quarter Jul 29 2016 
Roche Holdings Definitely Not a Lumbering Giant Jul 11 2016 
Spiros Segalas Buys McDonald's, Microsoft, Alibaba May 05 2016 
Kyle Bass Sells Stakes in 11 Health Care Companies Mar 01 2016 
J.P. Morgan’s 3 Biotechnology Picks Apr 14 2015 
You Can No Longer Ignore Biotech Feb 07 2014 
Weekly Top Insider Sells: AAPL, GILD, BMRN, and PCLN Nov 19 2012 
WEEKLY CFO SELLS HIGHLIGHT: VVUS, DIS, SNPS, TXRH, BMRN Mar 04 2012 
5 Resilient Biotech Stocks to Buy for 2012 Feb 28 2012 

More From Other Websites
What Do Analysts Say about Regeneron’s Upside Potential? Sep 30 2016
BioMarin Pharmaceutical, Inc. breached its 50 day moving average in a Bearish Manner : BMRN-US :... Sep 30 2016
Sarepta's Costly Muscular Dystrophy Drug Flirts With Big Pharma M&A Sep 28 2016
What’s the Upward Return Potential for BioMarin? Sep 28 2016
What’s the Word on Street for Vertex? Sep 28 2016
Sarepta: 'Yes, We're Aware Our Price Target is $50 Higher Than the Current Price' Sep 28 2016
A Look at BioMarin’s Early Stage Pipeline Sep 28 2016
How Promising is BioMarin’s Late-Stage Pipeline? Sep 27 2016
BioMarin to Cross $1 Billion Revenue in 2016 Sep 27 2016
What Are BioMarin’s Valuation Drivers? Sep 27 2016
BioMarin Takes Aim at Rival Sarepta (BMRN, SRPT) Sep 26 2016
Blue Jay Capital Betting On Big Returns From These Healthcare Stocks Sep 22 2016
Sarepta (SRPT) Stock Lower, BioMarin to Appeal Patent Ruling Sep 21 2016
Sarepta Therapeutics: BioMarin Still Wants a Piece of the Action Sep 21 2016
Patent Trial And Appeal Board Hands Sarepta Another Big Win Sep 21 2016
BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases... Sep 21 2016
BioMarin Reviews Status of Exon 51 Composition of Matter and Method of Use Patent Interference Cases... Sep 21 2016
[$$] Sarepta Soars 100% in a Week Yet Remains a Buy Sep 20 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)